Course overview
Transportation activities concentrate safety, security, service, contractual and financial risks in a small number of critical decisions: which routes to use, how assets are maintained, who controls handoffs, what insurance is purchased, and how incidents are managed. A collision, cargo theft, terminal closure, cyber incident or severe-weather disruption can trigger repair costs, claims, penalties, missed service commitments and reputational damage. Risk managers and transport leaders need a disciplined method for identifying exposures, assessing their significance and proving that controls work.
This course teaches a structured approach to transportation risk assessment and management using ISO 31000 principles, hazard identification, Bowtie analysis, FMEA, risk matrices and financial loss analysis. Participants assess operational, safety, security, cyber, environmental and contractual risks affecting road, rail, maritime, aviation and logistics activities. They learn to define risk appetite, build defensible risk registers, quantify selected loss scenarios, design controls, review insurance arrangements, prepare continuity responses and report material exposures to management and boards.
Teaching combines concise instructor briefings with transport cases, facilitated group analysis, risk-scoring simulations and application planning. Cases address realistic events such as fleet collisions, cargo losses, route disruption, contractor failures and dispatch-system outages. Participants leave with a Transportation Risk Management Pack containing reusable assessment templates, control-testing tools and a 90-day implementation plan. The course is delivered over five days in classrooms across 50+ cities or live online, with approximately 6.5 contact hours each day. Participants receive a certificate of completion.
The course suits professionals who already work with transport operations, logistics, safety, finance, insurance, compliance or business continuity and need to make risk decisions more consistent, evidence-based and commercially sound.



